This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Modernatx, Inc.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Phil White: Innovator in Human Cytomegalovirus Vaccination
Introduction: Phil White is a prominent inventor based in Cambridge, MA, known for his contributions to the field of vaccine development. With a focus on human cytomegalovirus (hCMV), White's work aims to enhance immune responses through innovative methodologies.
Latest Patents: Phil White holds a patent for a groundbreaking human cytomegalovirus vaccine. This patent includes aspects of producing an antigen-specific immune response to the hCMV by administering mRNA vaccines, representing a significant advancement in vaccine technology.
Career Highlights: Currently, Phil White is associated with ModernaTX, Inc., a leading company in mRNA technology and vaccine research. His career is marked by dedication to improving public health through innovative solutions in immunization.
Collaborations: Throughout his career, Phil has collaborated with talented professionals in the field, including his colleagues Jack F. Kramarczyk and Kimberly Hassett. Together, they contribute to the ongoing advancements in vaccine development and immune response strategies.
Conclusion: Phil White stands out as an inventor committed to pioneering advancements in vaccination against human cytomegalovirus. His work has the potential to impact public health significantly, and his dedication to innovation exemplifies the spirit of modern scientific research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile